AML1 deletion in adult mice causes splenomegaly and lymphomas

Oncogene

Volumn 25, Issue 6, 2006, Pages 929-939

  Putz, G ^a   Rosner, A ^b   Nuesslein, I ^a   Schmitz, N ^a   Buchholz, F ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

AML1; Conditional allele; Hematopoiesis; Lymphoma; Splenomegaly

Indexed keywords

CRE RECOMBINASE; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL COUNT; CELL MATURATION; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; GENE DELETION; HYPERPLASIA; KNOCKOUT GENE; LIVER METASTASIS; LOXP SITE; LYMPHATIC SYSTEM DISEASE; LYMPHOCYTOPENIA; LYMPHOMA; MEGAKARYOCYTE; MENINGEAL METASTASIS; MOUSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; ONCOGENE; PRELEUKEMIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; SPLEEN FUNCTION; SPLENOMEGALY; T LYMPHOCYTE; THROMBOCYTE ANOMALY; THROMBOCYTOPENIA; THYMOCYTE; THYMUS; THYMUS LYMPHOMA;

ANIMALS; BONE MARROW CELLS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; EXONS; GENE DELETION; GENETIC ENGINEERING; LYMPHOMA; MICE; MICE, TRANSGENIC; MYELODYSPLASTIC SYNDROMES; POLY I-C; PROMOTER REGIONS (GENETICS); SPLENOMEGALY; THROMBOCYTOPENIA; THYMUS GLAND;

ANIMALIA;

EID: 32544445732     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209136     Document Type: Article

References (41)

1. Bourgeois E, Caulier MT, Rose C, Dupriez B, Bauters F, Fenaux P. (2001). Leukemia 15: 950-953.
2. Buchholz F, Refaeli Y, Trumpp A, Bishop JM. (2000). EMBO Rep 1: 133-139.
3. Dunnick JK, Hardisty JF, Herbert RA, Seely JC, Furedi-Machacek EM, Foley JF et al. (1997). Toxicol Pathol 25: 533-540.
4. Fredrickson TN, Harris AW. (2000). Atlas of Mouse Hematopathology. Harwood Academic Publishers: Amsterdam.
5. Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR. (2002). Cancer Cell 1: 63-74.
6. Hirai H, Kobayashi Y, Mano H, Hagiwara K, Maru Y, Omine M et al. (1987). Nature 327: 430-432.
7. Hirai H, Okada M, Mizoguchi H, Mano H, Kobayashi Y, Nishida J et al. (1988). Blood 71: 256-258.
8. Ichikawa M, Asai T, Saito T, Yamamoto G, Seo S, Yamazaki I et al. (2004). Nat Med 10: 299-304.
9. Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Takeuchi K, Maki K et al. (2000). Blood 96: 3154-3160.
10. Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD, et al., Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium. (2002). Blood 100: 238-245.
11. Kuhn R, Schwenk F, Aguet M, Rajewsky K. (1995). Science 269: 1427-1429.
12. Lagasse E, Weissman IL. (1996). J Immunol Methods 197: 139-150.
13. Lenny N, Meyers S, Hiebert SW. (1995). Oncogene 11: 1761-1769.
14. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y. (1994). Genomics 23: 425-432.
15. Lorsbach RB, Moore J, Ang SO, Sun W, Lenny N, Downing JR. (2004). Blood 103: 2522-2529.
16. Michaud J, Scott HS, Escher R. (2003). Cancer Invest 21: 105-136.
17. Miller JD, Stacy T, Liu PP, Speck NA. (2001). Blood 97: 2248-2256.
18. Morohashi K, Tsuboi-Asai H, Matsushita S, Suda M, Nakashima M, Sasano H et al. (1999). Blood 93: 1586-1594.
19. North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M et al. (1999). Development 126: 2563-2575.
20. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y et al. (1993a). Virology 194: 314-331.
21. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M et al. (1993b). Proc Natl Acad Sci USA 90: 6859-6863.
22. Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM et al. (1998). Blood 91: 3134-3143.
23. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. (1996). Cell 84: 321-330.
24. Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T et al. (1999). Blood 93: 1817-1824.
25. Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL et al. (2000). Blood 96: 2862-2869.
26. Rhoades KL, Hetherington CJ, Harakawa N, Yergeau DA, Zhou L, Liu LQ et al. (2000). Blood 96: 2108-2115.
27. Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C. (2003). Leukemia 17: 9-16.
28. Rowley JD. (1998). Annu Rev Genet 32: 495-519.
29. Schiering A, Menschikowski M, Mueller E, Jaross W. (1999). Atherosclerosis 144: 73-78.
30. Silva FP, Morolli B, Storlazzi CT, Anelli L, Wessels H, Bezrookove V et al. (2003). Oncogene 22: 538-547.
31. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. (1999). Nat Genet 23: 166-175.
32. Steensma DP, Gibbons RJ, Mesa RA, Tefferi A, Higgs DR. (2005). Eur J Haematol 74: 47-53.
33. Sun W, Downing JR. (2004). Blood 104: 3565-3572.
34. Taketani T, Taki T, Takita J, Tsuchida M, Hanada R, Hongo T et al. (2003). Genes Chromosomes Cancer 38: 1-7.
35. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T et al. (2002). Cell 111: 621-633.
36. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. (1996a). Proc Natl Acad Sci USA 93: 3444-3449.
37. Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X et al. (1996b). Cell 87: 697-708.
38. Wang SW, Speck NA. (1992). Mol Cell Biol 12: 89-102.
39. Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M et al. (1997). Nat Genet 15: 303-306.
40. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG et al. (1997). Blood 90: 5002-5012.
41. Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ et al. (2001). Proc Natl Acad Sci USA 98: 10398-10403.